Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule
Clinical trial NCT02382640 · COMPLETED
Trial details
- NCT number
- NCT02382640
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2015-05-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.